W

Wedbush Securities

904 employees

Wedbush Securities is a company providing banking and investment services for any individual, institution, or issuing client.

Investor insights

Sectors invested in

Biotechnology4

Health Care4

Medical3

Financial Services2

Biotech1

Biopharma1

Pharmaceutical1

Life Science1

Therapeutics1

Inflammatory Disorders1

Targeted Protein Degredation1

Small Molecules1

Cancer1

Funding rounds participated in

$60M sweet spot round size

Most of their 7 investments are in rounds between $1.6M and $92M

Investor type

Investment Bank

Basic info

Industry

financial services

Sectors

Capital Markets

Financial Services

Investment Banking

Futures

Public Finance

Banking

Retail Brokerage

Equity Research

Clearing & Execution

Fixed Income

Private Equity

Wealth Management

Consulting

Prime Brokerage

Date founded

1955

Investments made

I

Inozyme Pharma raised $60M on July 27, 2023

Investors: Wedbush Securities

U

Undisclosed raised $11M on June 8, 2022

Investors: C Squared Fund, Belvedere Trading, LLC, ClearSky, BNY Mellon, SenaHill Partners, LP, Zilliqa Capital and Wedbush Securities

S

Sarna Finance raised $1.6M on April 28, 2022

Investors: Wedbush Securities

D

Dianthus Therapeutics, Inc. raised $100M on April 19, 2022

Investors: 5AM Ventures, Avidity Partners, Tellus BioVentures and Wedbush Securities

S

Shoreline Biosciences, Inc. raised $140M on November 2, 2021

Investors: NS Investment, Kingdon Capital Management, Irving Investors, Stork Capital S.à.r.l., -, Eventide Asset Management, Piper Sandler and Wedbush Securities

B

BioTheryX, Inc. raised $92M on May 20, 2021

Investors: Irving Investors, Lumira Ventures, Surveyor Capital, Farallon Capital Management, Point72 Asset Management, S.R. One Ltd, Tekla Capital Management and Wedbush Securities

S

Sarna Finance raised $950K on March 10, 2021

Investors: Motivate Venture Capital, Wedbush Ventures and Wedbush Securities